<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Afr J Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Afr J Infect Dis</journal-id><journal-id journal-id-type="publisher-id">AJID</journal-id><journal-title-group><journal-title>African Journal of Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">2006-0165</issn><issn pub-type="epub">2505-0419</issn><publisher><publisher-name>African Traditional Herbal Medicine Supporters Initiative (ATHMSI)</publisher-name><publisher-loc>Nigeria</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12102674</article-id><article-id pub-id-type="publisher-id">AJID-19-43</article-id><article-id pub-id-type="doi">10.21010/Ajidv19i2.5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>FAMILY SUPPORT, MOTIVATION, AND PATIENT ADHERENCE TO TUBERCULOSIS TREATMENT: INSIGHTS FROM INDONESIA</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dana</surname><given-names>NINDREA Ricvan</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Chiau</surname><given-names>MING Long</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Rahman</surname><given-names>AGUSTIAN Dede</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff3" ref-type="aff">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Medicine, Faculty of Medicine, Universitas Negeri Padang, Bukittinggi, Indonesia, 26181</aff><aff id="aff2"><label>2</label>School of Medical and Life Sciences, Sunway University, Malaysia, 47500</aff><aff id="aff3"><label>3</label>Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 406040</aff><author-notes><corresp id="cor1">
<label>*</label>
<bold>Corresponding Author&#x02019;s E-mail:</bold>
<email xlink:href="ricvan@fk.unp.ac.id">ricvan@fk.unp.ac.id</email>
</corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>07</day><month>4</month><year>2025</year></pub-date><volume>19</volume><issue>2</issue><fpage>43</fpage><lpage>49</lpage><history><date date-type="received"><day>20</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>01</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 Afr. J. Infect. Diseases</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Tuberculosis (TB) remains a significant public health issue globally, with patient adherence to treatment being critical for successful outcomes.</p><p>This study aimed to investigate the roles of family support and motivation in influencing adherence to TB treatment in Indonesia.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>A cross-sectional study was conducted among patients at four health centers in Padang Municipality, Indonesia, between January and November 2024. A total of 125 respondents diagnosed with drug-sensitive TB and in the second stage of treatment participated. Data were collected through structured interviews using validated questionnaires, assessing family support, motivation, and treatment adherence. Structural Equation Modeling (SEM) was used to analyze the relationships between variables.</p></sec><sec id="st3"><title>Results:</title><p>The findings revealed significant relationships between family support and motivation (&#x003b2; = 0.931, t-value = 47.016, P&#x0003c;0.001), family support and adherence to TB treatment (&#x003b2; = 0.229, t-value = 2.743, P=0.006), and motivation and adherence to TB treatment (&#x003b2; = 0.775, t-value = 9.334, P&#x0003c;0.001).</p></sec><sec id="st4"><title>Conclusion:</title><p>Family support and motivation play crucial roles in enhancing patient adherence to TB treatment. Strategies to strengthen family involvement and patient motivation should be integrated into TB control programs to improve treatment outcomes. Further research is recommended to explore additional factors influencing adherence in different contexts.</p></sec></abstract><kwd-group><kwd>Family support</kwd><kwd>Motivation</kwd><kwd>Treatment adherence</kwd><kwd>Tuberculosis</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Tuberculosis (TB) continues to be a critical global health issue, especially in low- and middle-income nations (Nindrea <italic>et al.</italic>, 2024). The World Health Organization (WHO) reports that TB is among the leading causes of mortality worldwide, with approximately 10.6 million new infections and 1.3 million deaths recorded in 2022 (Lestari <italic>et al.</italic>, 2023). Indonesia is among the top three countries contributing to the global TB burden, accounting for approximately 10% of the global TB cases (Lestari <italic>et al.</italic>, 2023). Despite efforts to reduce the TB burden, challenges such as poor treatment adherence, stigma, and limited access to healthcare services persist (Bedingfield <italic>et al.</italic>, 2023; Chen <italic>et al.</italic>, 2020).</p><p>Drug-sensitive tuberculosis (DS-TB), the most common form of TB, refers to cases caused by Mycobacterium tuberculosis that respond to first-line anti-TB drugs such as isoniazid and rifampin. DS-TB cases have a generally favorable prognosis when the full 6&#x02013;8 month treatment regimen recommended by the WHO is completed (Bedingfield <italic>et al.</italic>, 2023; Chen <italic>et al.</italic>, 2020). However, poor adherence to treatment remains a critical challenge, leading to treatment failure, relapse, and, in severe cases, the emergence of multidrug-resistant TB (MDR-TB) (Chowdhury <italic>et al.</italic>, 2023). Ensuring adherence in DS-TB cases is pivotal not only for individual recovery but also for breaking the cycle of TB transmission and preventing the development of drug-resistant strains. In Indonesia, where TB incidence remains high, addressing barriers to adherence in DS-TB is an urgent public health priority (Sazali <italic>et al.</italic>, 2023).</p><p>Adherence to TB treatment is critical for successful outcomes. The WHO recommends a 6&#x02013;8 month treatment regimen for drug-sensitive TB, but many patients fail to complete this due to personal, social, and economic barriers (Sazali <italic>et al.</italic>, 2023; Chowdhury <italic>et al.</italic>, 2023). Research indicates that family support and motivation are significant determinants of TB treatment adherence (Gebremariam <italic>et al.</italic>, 2021; Lutfian <italic>et al.</italic>, 2025). Family support, both emotional and practical, provides TB patients with encouragement, reminders, and assistance throughout the prolonged treatment journey (Dilas <italic>et al.</italic>, 2023; Lutfian <italic>et al.</italic>, 2025). It helps patients overcome barriers such as fatigue, stigma, and financial burdens (Nagarajan <italic>et al.</italic>, 2022; Wong <italic>et al.</italic>, 2021). Similarly, patient motivation shaped by personal awareness of the disease, family encouragement, and healthcare provider support plays a vital role in sustaining adherence to treatment regimens (Yadav <italic>et al.</italic>, 2024; Dilas <italic>et al.</italic>, 2023).</p><p>In Indonesia, socio-cultural factors further complicate TB treatment adherence. The strong family-oriented culture can serve as a vital support system for TB patients (Lolong <italic>et al.</italic>, 2023). However, stigma and misconceptions surrounding TB remain prevalent, causing some patients to delay treatment or conceal their condition (Ashaba <italic>et al.</italic>, 2021). Understanding how family support and motivation influence TB treatment adherence in this setting is essential to designing effective interventions (Saidi <italic>et al.</italic>, 2023).</p><p>This study aims to investigate the relationship between family support, motivation, and patient adherence to TB treatment in Indonesia. By identifying these key factors, the findings can inform targeted interventions to improve TB treatment outcomes and strengthen the country&#x02019;s efforts to meet global TB elimination targets by 2030, as outlined in the WHO End TB Strategy.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Study design and research sample</title><p>A cross-sectional study was conducted to examine patients seeking care at four health centers in Padang Municipality, Indonesia. Data collection took place from January to November 2024. The survey focused on patients diagnosed with drug-sensitive TB who had advanced to stage 2, representing individuals with active disease following infection. However, patients in the second stage who were merely exposed without disease progression, along with those diagnosed with extensively drug-resistant tuberculosis (XDR TB) or MDR TB, were excluded from participation. For the sample size calculation, we hypothesized that 91% of patients with family support adhere to tuberculosis treatment (p = 0.91 p=0.91) (Nindrea <italic>et al.</italic>, 2024). With a 95% confidence level and a 5% margin of error, the required sample size was determined to be 125 respondents. Sample selection utilized multistage stratified clustered sampling.</p></sec><sec id="sec2-2"><title>Variables and operational definitions</title><p>The constructs in this study were defined and measured using reliable and validated scales derived from established peer-reviewed journals. Patient adherence to TB treatment was assessed through four questions: whether healthcare providers give clear and timely advice about treatment during visits to the health center, whether patients are aware of their sputum test schedule, whether doctors express concern about disease progression during consultations, and whether patients are asked to provide sputum samples during health center visits (Dilas <italic>et al.</italic>, 2023). Family support was evaluated using five statements: the family provides emotional support during TB treatment, encourages the completion of treatment, shares information to help understand the importance of TB treatment, reminds the patient about their medication schedule, and assists with daily necessities during treatment (Nindrea <italic>et al.</italic>, 2024). Motivation was measured through five statements: understanding the importance of completing TB treatment for recovery, believing that completing treatment improves quality of life, feeling motivated by family support to stay committed to treatment, receiving encouragement from healthcare providers to complete treatment, and not experiencing community stigma that diminishes motivation to complete treatment (Dilas <italic>et al.</italic>, 2023; Nindrea <italic>et al.</italic>, 2024). All variables were measured using a Likert scale. The instruments used in this study to assess patient adherence to TB treatment, family support, and motivation demonstrated robust content and construct validity, with reliability confirmed by a Cronbach&#x02019;s alpha greater than 0.7, indicating high internal consistency (Dilas <italic>et al.</italic>, 2023; Nindrea <italic>et al.</italic>, 2024).</p></sec><sec id="sec2-3"><title>Data collection</title><p>The study employed a research questionnaire to collect data. Informed consent was obtained from all respondents, who were assured that their participation was entirely voluntary and that they could withdraw at any time without any consequences. To ensure confidentiality, respondents&#x02019; identities were anonymized, and no names were disclosed to prevent any potential repercussions.</p></sec><sec id="sec2-4"><title>Ethical approval</title><p>This study received ethical approval from the Research Ethics Committee of General Hospital of Dr. M. Djamil in Padang Municipality, Indonesia (No. DP.04.03/D.XVI.XI/539/2023).</p></sec><sec id="sec2-5"><title>Data analysis</title><p>In this study, descriptive statistics, such as frequencies, percentages, and median values, were utilized. The reliability and validity of the measurement scales were assessed using Cronbach&#x02019;s alpha, CR, and AVE. Furthermore, SEM was employed to test the research hypotheses, with a significance level set at P &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p><xref rid="T1" ref-type="table">Table 1</xref> shows that the average age of the respondents was 41.52&#x000b1;3.61 years. Most respondents were male, accounting for 56.0% of the sample. Over half of the participants reported a family income below 2,810,000 IDR (68.8%). The average number of family members was 4.51&#x000b1;0.23. Junior high school was the most frequently reported level of education, and the most common occupation was entrepreneurship, representing 28.0% of the group (<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Characteristics of respondents</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Value (n=125)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Age (years), (mean&#x000b1;SD)</bold>
</td><td align="center" rowspan="1" colspan="1">41.52&#x000b1;3.61</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Sex, f(%)</bold>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">70 (56.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">55 (44.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Family income based on regional minimum wage, f(%)</bold>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003c; 2,810,000 IDR</td><td align="center" rowspan="1" colspan="1">86 (68.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02265; 2,810,000 IDR</td><td align="center" rowspan="1" colspan="1">39 (31.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of family members, (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">4.51&#x000b1;0.23</td></tr><tr><td align="left" rowspan="1" colspan="1">Educational level, f(%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No schooling</td><td align="center" rowspan="1" colspan="1">11 (8.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Elementary school</td><td align="center" rowspan="1" colspan="1">27 (21.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Junior high school</td><td align="center" rowspan="1" colspan="1">51 (40.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Senior high school</td><td align="center" rowspan="1" colspan="1">32 (25.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">University</td><td align="center" rowspan="1" colspan="1">4 (3.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Occupation, f(%)</bold>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Government employee</td><td align="center" rowspan="1" colspan="1">22 (17.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Private sector employee</td><td align="center" rowspan="1" colspan="1">20 (16.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Entrepreneur</td><td align="center" rowspan="1" colspan="1">35 (28.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Small-scale merchant</td><td align="center" rowspan="1" colspan="1">28 (22.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Farmer</td><td align="center" rowspan="1" colspan="1">20 (16.0)</td></tr></tbody></table></table-wrap><p><xref rid="T2" ref-type="table">Table 2</xref> demonstrated that all standardized factor loadings were above 0.60 and statistically significant (P&#x0003c;0.05). The reliability of the variables was evaluated through Cronbach&#x02019;s alpha, with all values exceeding 0.70, confirming the reliability of the variables. Convergent validity of the scales was assessed based on three criteria: first, all indicator loadings were greater than 0.70; second, CR values exceeded 0.8; and third, the AVE for each construct was 0.5 or higher. These findings indicated that the research constructs achieved satisfactory convergent validity (<xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Findings on confirmatory factor analysis</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Constructs/ factors</th><th align="center" rowspan="1" colspan="1">Standardized factor loadings</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>Patient adherence to TB treatment (&#x003b1;=0.926; CR=0.948; AVE=0.819)</italic>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PAT1 - When visiting the health center, do the health personnel provide you with clear and timely advice about your treatment?</td><td align="center" rowspan="1" colspan="1">0.914</td></tr><tr><td align="left" rowspan="1" colspan="1">PAT2 - Are you aware of when your sputum test is scheduled?</td><td align="center" rowspan="1" colspan="1">0.902</td></tr><tr><td align="left" rowspan="1" colspan="1">PAT3- Does the doctor express concern about the progression of your disease during consultations?</td><td align="center" rowspan="1" colspan="1">0.914</td></tr><tr><td align="left" rowspan="1" colspan="1">PAT4-Are you asked to provide a sputum sample when you visit the health center?</td><td align="center" rowspan="1" colspan="1">0.890</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Family support (&#x003b1;=0.924; CR=0.944; AVE=0.771)</italic>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">FS1- I feel that my family provides emotional support during my TB treatment</td><td align="center" rowspan="1" colspan="1">0.932</td></tr><tr><td align="left" rowspan="1" colspan="1">FS2 - My family encourages me to complete my TB treatment</td><td align="center" rowspan="1" colspan="1">0.840</td></tr><tr><td align="left" rowspan="1" colspan="1">FS3 - My family provides information that helps me understand the importance of TB treatment</td><td align="center" rowspan="1" colspan="1">0.927</td></tr><tr><td align="left" rowspan="1" colspan="1">FS4 - My family members remind me about my medication schedule</td><td align="center" rowspan="1" colspan="1">0.735</td></tr><tr><td align="left" rowspan="1" colspan="1">FS5 - My family helps me with daily necessities while I undergo TB treatment</td><td align="center" rowspan="1" colspan="1">0.940</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Motivation</italic>
<italic>(&#x003b1;=0.938; CR=0.953; AVE=0.804)</italic></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">M1 - I understand the importance of completing TB treatment for my recovery</td><td align="center" rowspan="1" colspan="1">0.862</td></tr><tr><td align="left" rowspan="1" colspan="1">M2 - I believe that completing TB treatment will improve my quality of life</td><td align="center" rowspan="1" colspan="1">0.894</td></tr><tr><td align="left" rowspan="1" colspan="1">M3 - Support from my family motivates me to stay committed to the treatment</td><td align="center" rowspan="1" colspan="1">0.916</td></tr><tr><td align="left" rowspan="1" colspan="1">M4 - Healthcare providers offer encouragement that inspires me to complete the treatment</td><td align="center" rowspan="1" colspan="1">0.894</td></tr><tr><td align="left" rowspan="1" colspan="1">M5 - I do not experience stigma from the community that could diminish my motivation to complete the treatment</td><td align="center" rowspan="1" colspan="1">0.916</td></tr></tbody></table><table-wrap-foot><fn><p>&#x003b1;= Cronbach&#x02019;s alpha</p></fn></table-wrap-foot></table-wrap><p><xref rid="T3" ref-type="table">Table 3</xref> evaluated discriminant validity, which reflects the degree to which the three variables are empirically distinct from one another. To establish discriminant validity, the AVE of each latent construct needed to exceed the squared correlations between that construct and all other latent constructs. The results confirmed that these criteria for discriminant validity were met (<xref rid="T3" ref-type="table">Table 3</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Findings on discriminant validity</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">No</th><th align="center" rowspan="1" colspan="1">Constructs</th><th align="center" rowspan="1" colspan="1">1</th><th align="center" rowspan="1" colspan="1">2</th><th align="center" rowspan="1" colspan="1">3</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Family support</td><td align="center" rowspan="1" colspan="1">
<italic>0.878</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Motivation</td><td align="center" rowspan="1" colspan="1">0.490</td><td align="center" rowspan="1" colspan="1">
<italic>0.897</italic>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Patient adherence to TB treatment</td><td align="center" rowspan="1" colspan="1">0.423</td><td align="center" rowspan="1" colspan="1">0.563</td><td align="center" rowspan="1" colspan="1">
<italic>0.905</italic>
</td></tr></tbody></table></table-wrap><p><xref rid="T4" ref-type="table">Table 4</xref> and <xref rid="F1" ref-type="fig">Figure 1</xref> depict the relationships between the study variables. A strong association was observed between family support and motivation (&#x003b2; = 0.931, t-value = 47.016, P &#x0003c; 0.001). Additionally, family support was positively linked to patient adherence to TB treatment (&#x003b2; = 0.229, t-value = 2.743, P = 0.006), while motivation also showed a significant positive relationship with patient adherence (&#x003b2; = 0.775, t-value = 9.334, P &#x0003c; 0.001). (<xref rid="T4" ref-type="table">Table 4</xref> and <xref rid="F1" ref-type="fig">Figure 1</xref>).</p><table-wrap position="float" id="T4"><label>Tabel 4</label><caption><p>The relationship between family support, motivation, and patient adherence to TB treatment in Indonesia</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Path specified</th><th align="center" rowspan="1" colspan="1">Coefficient (&#x003b2;)</th><th align="center" rowspan="1" colspan="1">t-value</th><th align="center" rowspan="1" colspan="1">P-value</th><th align="center" rowspan="1" colspan="1">Result</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Family support -&#x0003e; Motivation</td><td align="center" rowspan="1" colspan="1">0.931</td><td align="center" rowspan="1" colspan="1">47.016</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">Accepted</td></tr><tr><td align="left" rowspan="1" colspan="1">Family support -&#x0003e; Patient adherence to TB treatment</td><td align="center" rowspan="1" colspan="1">0.229</td><td align="center" rowspan="1" colspan="1">2.743</td><td align="center" rowspan="1" colspan="1">0.006</td><td align="center" rowspan="1" colspan="1">Accepted</td></tr><tr><td align="left" rowspan="1" colspan="1">Motivation -&#x0003e; Patient adherence to TB treatment</td><td align="center" rowspan="1" colspan="1">0.775</td><td align="center" rowspan="1" colspan="1">9.334</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">Accepted</td></tr></tbody></table></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p>A path analysis of the relationship between family support, motivation, and patient adherence to TB treatment in Indonesia.</p></caption><graphic xlink:href="AJID-19-43-g001" position="float"/></fig></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>This study highlights the significant roles of family support and motivation in improving adherence to TB treatment. Consistent with previous research, the findings affirm that family support serves as a critical determinant in encouraging patients to adhere to TB treatment regimens (Lutfian <italic>et al.</italic>, 2025). Other studies have similarly demonstrated that emotional, informational, and practical support from family members can significantly influence patient behavior, particularly in chronic disease management (Strom <italic>et al.</italic>, 2012; Hendriyani <italic>et al.</italic>, 2020; Bradshaw <italic>et al.</italic>, 2022). Likewise, motivation, driven by patient awareness and external encouragement, aligns with prior studies showing its pivotal role in fostering adherence to treatment protocols (Nindrea <italic>et al.</italic>, 2020; Fahmi <italic>et al.</italic>, 2021).</p><p>The study phenomena underscore the influence of cultural and demographic characteristics on treatment adherence (Widayanti <italic>et al.</italic>, 2023). In Indonesia, family units often play a central role in an individual&#x02019;s decision-making and daily activities due to collectivist cultural norms (Soemantri <italic>et al.</italic>, 2021). This cultural context likely amplifies the impact of family support on patient motivation and adherence (Febriyanti <italic>et al.</italic>, 2024). The demographic characteristics of the respondents, such as their predominantly low-income status and varying educational levels, further emphasize the importance of family support in bridging gaps in healthcare literacy and accessibility (Coombs <italic>et al.</italic>, 2022; Nindrea <italic>et al.</italic>, 2022). Families not only provide emotional support but also help manage logistical challenges, such as reminding patients of appointments and ensuring medication adherence, which are particularly crucial in resource-limited settings (Kvarnstr&#x000f6;m <italic>et al.</italic>, 2021; Cross <italic>et al.</italic>, 2020).</p><p>The implications of these findings are far-reaching. Health programs should integrate family-centered approaches into TB care, providing education and resources to families to enhance their supportive roles (Myburgh et al., 2023). Additionally, motivational strategies tailored to individual patient needs, such as counseling or community support, can further strengthen adherence outcomes (Fernandes <italic>et al.</italic>, 2023; Dilas <italic>et al.</italic>, 2023; Nindrea <italic>et al.</italic>, 2019). Public health initiatives should also consider cultural dynamics and address demographic disparities to ensure equitable access and adherence to TB treatment.</p><p>The study&#x02019;s strengths include its robust methodological design, validated measurement tools, and the use of SEM to analyze complex relationships among variables. However, some limitations should be acknowledged. The study was conducted in a single municipality, potentially limiting the generalizability of the findings. Furthermore, the cross-sectional design precludes causal inferences, and the reliance on self-reported data may introduce bias.</p><p>Future research should explore longitudinal designs to confirm causal relationships and extend the scope to diverse populations and settings. Additional studies should also investigate how cultural norms and socioeconomic factors intersect with family support and motivation to influence TB treatment adherence. Despite its limitations, this study provides valuable insights into the psychosocial and cultural factors influencing TB treatment adherence, specifically through the lenses of family support and patient motivation. The cultural context, particularly Indonesia&#x02019;s collectivist norms, amplifies the role of family as a primary source of emotional, informational, and logistical support, directly impacting patients&#x02019; adherence behavior. By focusing on these variables, the study emphasizes the importance of tailoring interventions to cultural and familial dynamics to enhance treatment outcomes.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>This study highlights the critical roles of family support and motivation in improving adherence to TB treatment. Family support enhances motivation and adherence through emotional, informational, and practical assistance, particularly in a collectivist cultural context like Indonesia. The findings emphasize the need for family-centered approaches and motivational strategies in TB care, addressing psychosocial and socioeconomic factors to optimize outcomes. Future research should explore these dynamics further across diverse populations and settings to inform more effective TB treatment strategies.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors express their gratitude to all the respondents who took part in this study.</p></ack><sec sec-type="COI-statement" id="sec2-6"><title>Conflict of Interest</title><p>The authors declare that there is no conflict of interest associated with this study.</p><def-list><title>List of Abbreviations0:</title><def-item><term>AVE:</term><def><p>Average Variance Extracted:</p></def></def-item><def-item><term>CR:</term><def><p>Composite Reliability:</p></def></def-item><def-item><term>DS-TB:</term><def><p>Drug-sensitive tuberculosis:</p></def></def-item><def-item><term>MDR TB:</term><def><p>Multidrug-Resistant Tuberculosis:</p></def></def-item><def-item><term>SEM:</term><def><p>Structural Equation Modeling:</p></def></def-item><def-item><term>TB:</term><def><p>Tuberculosis</p></def></def-item><def-item><term>XDR TB:</term><def><p>Extensively Drug-Resistant Tuberculosis.</p></def></def-item></def-list></sec><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ashaba</surname><given-names>C</given-names></name>
<name><surname>Musoke</surname><given-names>D</given-names></name>
<name><surname>Wafula</surname><given-names>S.T</given-names></name>
<name><surname>Konde-Lule</surname><given-names>J</given-names></name>
</person-group><year>2021</year><article-title>Stigma among tuberculosis patients and associated factors in urban slum populations in Uganda</article-title><source>African Health Sciences</source><volume>21</volume><issue>4</issue><fpage>1640</fpage><lpage>1650</lpage><pub-id pub-id-type="pmid">35283968</pub-id>
</element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bedingfield</surname><given-names>N</given-names></name>
<name><surname>Lashewicz</surname><given-names>B</given-names></name>
<name><surname>Fisher</surname><given-names>D</given-names></name>
<name><surname>King-Shier</surname><given-names>K</given-names></name>
</person-group><year>2023</year><article-title>Canadian tuberculosis health care workers'perspectives on education and counselling for patients and family members who are born outside of Canada</article-title><source>Global Public Health</source><volume>18</volume><issue>1</issue><fpage>2174265</fpage><pub-id pub-id-type="pmid">36789497</pub-id>
</element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bradshaw</surname><given-names>J</given-names></name>
<name><surname>Siddiqui</surname><given-names>N</given-names></name>
<name><surname>Greenfield</surname><given-names>D</given-names></name>
<name><surname>Sharma</surname><given-names>A</given-names></name>
</person-group><year>2022</year><article-title>Kindness, listening, and connection:patient and clinician key requirements for emotional support in chronic and complex care</article-title><source>Journal of Patient Experience</source><volume>9</volume><fpage>23743735221092627</fpage><pub-id pub-id-type="pmid">35434291</pub-id>
</element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Du</surname><given-names>L</given-names></name>
<name><surname>Wu</surname><given-names>R</given-names></name>
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Ji</surname><given-names>H</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
</person-group><year>2020</year><article-title>The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients:a cross-sectional study</article-title><source>BMC Infectious Diseases</source><volume>20</volume><issue>1</issue><fpage>623</fpage><pub-id pub-id-type="pmid">32831050</pub-id>
</element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chowdhury</surname><given-names>K</given-names></name>
<name><surname>Ahmad</surname><given-names>R</given-names></name>
<name><surname>Sinha</surname><given-names>S</given-names></name>
<name><surname>Dutta</surname><given-names>S</given-names></name>
<name><surname>Haque</surname><given-names>M</given-names></name>
</person-group><year>2023</year><article-title>Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children:Where We Stand Now</article-title><source>Cureus</source><volume>15</volume><issue>2</issue><fpage>e35154</fpage><pub-id pub-id-type="pmid">36819973</pub-id>
</element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coombs</surname><given-names>N.C</given-names></name>
<name><surname>Campbell</surname><given-names>D.G</given-names></name>
<name><surname>Caringi</surname><given-names>J</given-names></name>
</person-group><year>2022</year><article-title>A qualitative study of rural healthcare providers'views of social, cultural, and programmatic barriers to healthcare access</article-title><source>BMC Health Services Research</source><volume>22</volume><issue>1</issue><fpage>438</fpage><pub-id pub-id-type="pmid">35366860</pub-id>
</element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cross</surname><given-names>A.J</given-names></name>
<name><surname>Elliott</surname><given-names>R.A</given-names></name>
<name><surname>Petrie</surname><given-names>K</given-names></name>
<name><surname>Kuruvilla</surname><given-names>L</given-names></name>
<name><surname>George</surname><given-names>J</given-names></name>
</person-group><year>2020</year><article-title>Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications</article-title><source>The Cochrane Database of Systematic Reviews</source><volume>5</volume><issue>5</issue><fpage>CD012419</fpage><pub-id pub-id-type="pmid">32383493</pub-id>
</element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dilas</surname><given-names>D</given-names></name>
<name><surname>Flores</surname><given-names>R</given-names></name>
<name><surname>Morales-Garc&#x000ed;a</surname><given-names>W.C</given-names></name>
<name><surname>Calizaya-Milla</surname><given-names>Y.E</given-names></name>
<name><surname>Morales-Garc&#x000ed;a</surname><given-names>M</given-names></name>
<name><surname>Sairitupa-Sanchez</surname><given-names>L</given-names></name>
<name><surname>Saintila</surname><given-names>J</given-names></name>
</person-group><year>2023</year><article-title>Social support, quality of care, and patient adherence to tuberculosis treatment in Peru:the mediating role of nurse health education</article-title><source>Patient preference and adherence</source><volume>17</volume><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">36704124</pub-id>
</element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fahmi</surname><given-names>M.N</given-names></name>
<name><surname>Pradjatmo</surname><given-names>H</given-names></name>
<name><surname>Astuti</surname><given-names>I</given-names></name>
<name><surname>Nindrea</surname><given-names>R.D</given-names></name>
</person-group><year>2021</year><article-title>Cytokines as prognostic biomarkers of epithelial ovarian cancer (EOC):a systematic review and meta-analysis</article-title><source>Asian Pacific Journal of Cancer Prevention :APJCP</source><volume>22</volume><issue>2</issue><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">33639643</pub-id>
</element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Febriyanti</surname><given-names>R.M</given-names></name>
<name><surname>Saefullah</surname><given-names>K</given-names></name>
<name><surname>Susanti</surname><given-names>R.D</given-names></name>
<name><surname>Lestari</surname><given-names>K</given-names></name>
</person-group><year>2024</year><article-title>Knowledge, attitude, and utilization of traditional medicine within the plural medical system in West Java, Indonesia</article-title><source>BMC Complementary Medicine and Therapies</source><volume>24</volume><issue>1</issue><fpage>64</fpage><pub-id pub-id-type="pmid">38287364</pub-id>
</element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>J.B</given-names></name>
<name><surname>Ferreira</surname><given-names>N</given-names></name>
<name><surname>Domingos</surname><given-names>J</given-names></name>
<name><surname>Ferreira</surname><given-names>R</given-names></name>
<name><surname>Amador</surname><given-names>C</given-names></name>
<name><surname>Pardal</surname><given-names>N</given-names></name>
</person-group><year>2023</year><article-title>Health Professionals'Motivational Strategies to Enhance Adherence in the Rehabilitation of People with Lower Limb Fractures:Scoping Review</article-title><source>International Journal of Environmental Research and Public Health</source><volume>20</volume><issue>22</issue><fpage>7050</fpage><pub-id pub-id-type="pmid">37998282</pub-id>
</element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gebremariam</surname><given-names>R.B</given-names></name>
<name><surname>Wolde</surname><given-names>M</given-names></name>
<name><surname>Beyene</surname><given-names>A</given-names></name>
</person-group><year>2021</year><article-title>Determinants of adherence to anti-TB treatment and associated factors among adult TB patients in Gondar city administration, Northwest, Ethiopia:based on health belief model perspective</article-title><source>Journal of Health, Population, and Nutrition</source><volume>40</volume><issue>1</issue><fpage>49</fpage><pub-id pub-id-type="pmid">34838120</pub-id>
</element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hendriyani</surname><given-names>H</given-names></name>
<name><surname>Sudargo</surname><given-names>T</given-names></name>
<name><surname>Lusmilasari</surname><given-names>L</given-names></name>
<name><surname>Helmyati</surname><given-names>S</given-names></name>
<name><surname>Susetyowati</surname><given-names>S</given-names></name>
<name><surname>Nindrea</surname><given-names>R.D</given-names></name>
</person-group><year>2020</year><article-title>Complementary feeding self-efficacy:a concept analysis</article-title><source>Open Access Macedonian Journal of Medical Sciences</source><volume>8</volume><fpage>11</fpage><lpage>22</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kvarnstr&#x000f6;m</surname><given-names>K</given-names></name>
<name><surname>Westerholm</surname><given-names>A</given-names></name>
<name><surname>Airaksinen</surname><given-names>M</given-names></name>
<name><surname>Liira</surname><given-names>H</given-names></name>
</person-group><year>2021</year><article-title>Factors Contributing to Medication Adherence in Patients with a Chronic Condition:A Scoping Review of Qualitative Research</article-title><source>Pharmaceutics</source><volume>13</volume><issue>7</issue><fpage>1100</fpage><pub-id pub-id-type="pmid">34371791</pub-id>
</element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lestari</surname><given-names>B.W</given-names></name>
<name><surname>Nijman</surname><given-names>G</given-names></name>
<name><surname>Larasmanah</surname><given-names>A</given-names></name>
<name><surname>Soeroto</surname><given-names>A.Y</given-names></name>
<name><surname>Santoso</surname><given-names>P</given-names></name>
<name><surname>Alisjahbana</surname><given-names>B</given-names></name>
</person-group><year>2023</year><article-title>Management of drug-resistant tuberculosis in Indonesia:a four-year cascade of care analysis</article-title><source>The Lancet Regional Health Southeast Asia</source><volume>22</volume><fpage>100294</fpage><pub-id pub-id-type="pmid">38482149</pub-id>
</element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lolong</surname><given-names>D.B</given-names></name>
<name><surname>Aryastami</surname><given-names>N.K</given-names></name>
<name><surname>Kusrini</surname><given-names>I</given-names></name>
<name><surname>Tobing</surname><given-names>K.L</given-names></name>
<name><surname>Tarigan</surname><given-names>I</given-names></name>
<name><surname>Isfandari</surname><given-names>S</given-names></name>
</person-group><year>2023</year><article-title>Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia</article-title><source>PloS One</source><volume>18</volume><issue>8</issue><fpage>e0287628</fpage><pub-id pub-id-type="pmid">37552679</pub-id>
</element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lutfian</surname><given-names>L</given-names></name>
<name><surname>Azizah</surname><given-names>A</given-names></name>
<name><surname>Wardika</surname><given-names>I.J</given-names></name>
<name><surname>Wildana</surname><given-names>F</given-names></name>
<name><surname>Maulana</surname><given-names>S</given-names></name>
<name><surname>Wartakusumah</surname><given-names>R</given-names></name>
</person-group><year>2025</year><article-title>The role of family support in medication adherence and quality of life among tuberculosis patients:A scoping review</article-title><source>Japan Journal of Nursing Science:JJNS</source><volume>22</volume><issue>1</issue><fpage>e12629</fpage><pub-id pub-id-type="pmid">39419582</pub-id>
</element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Myburgh</surname><given-names>H</given-names></name>
<name><surname>Baloyi</surname><given-names>D</given-names></name>
<name><surname>Loveday</surname><given-names>M</given-names></name>
<name><surname>Meehan</surname><given-names>S.A</given-names></name>
<name><surname>Osman</surname><given-names>M</given-names></name>
<name><surname>Wademan</surname><given-names>D</given-names></name>
</person-group><year>2023</year><article-title>A scoping review of patient-centred tuberculosis care interventions:Gaps and opportunities</article-title><source>PLOS Global Public Health</source><volume>3</volume><issue>2</issue><fpage>e0001357</fpage><pub-id pub-id-type="pmid">36963071</pub-id>
</element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagarajan</surname><given-names>K</given-names></name>
<name><surname>Kumarsamy</surname><given-names>K</given-names></name>
<name><surname>Begum</surname><given-names>R</given-names></name>
<name><surname>Panibatla</surname><given-names>V</given-names></name>
<name><surname>Reddy</surname><given-names>R</given-names></name>
<name><surname>Adepu</surname><given-names>R</given-names></name>
</person-group><year>2022</year><article-title>A dual perspective of psycho-social barriers and challenges experienced by drug-resistant TB patients and their caregivers through the course of diagnosis and treatment:findings from a qualitative study in Bengaluru and Hyderabad Districts of South India</article-title><source>Antibiotics (Basel, Switzerland)</source><volume>11</volume><issue>11</issue><fpage>1586</fpage><pub-id pub-id-type="pmid">36358241</pub-id>
</element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nindrea</surname><given-names>R. D</given-names></name>
<name><surname>Aryandono</surname><given-names>T</given-names></name>
<name><surname>Lazuardi</surname><given-names>L</given-names></name>
<name><surname>Dwiprahasto</surname><given-names>I</given-names></name>
</person-group><year>2019</year><article-title>Family history of breast cancer and breast cancer risk between malays ethnicity in Malaysia and Indonesia:a meta-analysis</article-title><source>Iranian Journal of Public Health</source><volume>48</volume><issue>2</issue><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">31205873</pub-id>
</element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nindrea</surname><given-names>R.D</given-names></name>
<name><surname>Djanas</surname><given-names>D</given-names></name>
<name><surname>Warsiti</surname><given-names>W</given-names></name>
<name><surname>Darma</surname><given-names>I.Y</given-names></name>
<name><surname>Hendriyani</surname><given-names>H</given-names></name>
<name><surname>Sari</surname><given-names>N.P</given-names></name>
</person-group><year>2022</year><article-title>The risk factors and pregnant women's willingness toward the SARS-CoV-2 vaccination in various countries:a systematic review and meta-analysis</article-title><source>Clinical Epidemiology and Global Health</source><volume>14</volume><fpage>100982</fpage><pub-id pub-id-type="pmid">35169659</pub-id>
</element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nindrea</surname><given-names>R.D</given-names></name>
<name><surname>Rika</surname><given-names>S</given-names></name>
<name><surname>Alexander</surname><given-names>M. B</given-names></name>
<name><surname>Muthia</surname><given-names>S</given-names></name>
<name><surname>Linda</surname><given-names>R</given-names></name>
<name><surname>Astri</surname><given-names>W</given-names></name>
</person-group><year>2024</year><article-title>Modifiable and non-modifiable risk factors for tuberculosis among adults in Indonesia:a systematic review and meta-analysis</article-title><source>African Journal of Infectious Diseases</source><volume>18</volume><issue>2</issue><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">38606192</pub-id>
</element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nindrea</surname><given-names>R.D</given-names></name>
<name><surname>Sari</surname><given-names>N.P</given-names></name>
<name><surname>Harahap</surname><given-names>W.A</given-names></name>
<name><surname>Haryono</surname><given-names>S.J</given-names></name>
<name><surname>Kusnanto</surname><given-names>H</given-names></name>
<name><surname>Dwiprahasto</surname><given-names>I</given-names></name>
</person-group><year>2020</year><article-title>Survey data of COVID-19 awareness, knowledge, preparedness and related behaviors among breast cancer patients in Indonesia</article-title><source>Data in Brief</source><volume>32</volume><fpage>106145</fpage><pub-id pub-id-type="pmid">32835041</pub-id>
</element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saidi</surname><given-names>S.S</given-names></name>
<name><surname>Abdul Manaf</surname><given-names>R</given-names></name>
</person-group><year>2023</year><article-title>Effectiveness of family support health education intervention to improve health-related quality of life among pulmonary tuberculosis patients in Melaka, Malaysia</article-title><source>BMC Pulmonary Medicine</source><volume>23</volume><issue>1</issue><fpage>139</fpage><pub-id pub-id-type="pmid">37098515</pub-id>
</element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sazali</surname><given-names>M.F</given-names></name>
<name><surname>Rahim</surname><given-names>S.S.S.A</given-names></name>
<name><surname>Mohammad</surname><given-names>A.H</given-names></name>
<name><surname>Kadir</surname><given-names>F</given-names></name>
<name><surname>Payus</surname><given-names>A.O</given-names></name>
<name><surname>Avoi</surname><given-names>R</given-names></name>
</person-group><year>2023</year><article-title>Improving tuberculosis medication adherence:the potential of integrating digital technology and health belief model</article-title><source>Tuberculosis and Respiratory Diseases</source><volume>86</volume><issue>2</issue><fpage>82</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">36597583</pub-id>
</element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soemantri</surname><given-names>D</given-names></name>
<name><surname>Greviana</surname><given-names>N</given-names></name>
<name><surname>Findyartini</surname><given-names>A</given-names></name>
<name><surname>Azzahra</surname><given-names>T.B</given-names></name>
<name><surname>Suryoadji</surname><given-names>K.A</given-names></name>
<name><surname>Mustika</surname><given-names>R</given-names></name>
<name><surname>Felaza</surname><given-names>E</given-names></name>
</person-group><year>2021</year><article-title>&#x0201c;To obey or not to obey&#x0201d;- Medical students'response towards professional dilemmas in a hierarchical and collectivist culture</article-title><source>PloS One</source><volume>16</volume><issue>12</issue><fpage>e0261828</fpage><pub-id pub-id-type="pmid">34941959</pub-id>
</element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strom</surname><given-names>J.L</given-names></name>
<name><surname>Egede</surname><given-names>L.E</given-names></name>
</person-group><year>2012</year><article-title>The impact of social support on outcomes in adult patients with type 2 diabetes:a systematic review</article-title><source>Current Diabetes Reports</source><volume>12</volume><issue>6</issue><fpage>769</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">22949135</pub-id>
</element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Widayanti</surname><given-names>A.W</given-names></name>
<name><surname>Green</surname><given-names>J.A</given-names></name>
<name><surname>Heydon</surname><given-names>S</given-names></name>
<name><surname>Norris</surname><given-names>P</given-names></name>
</person-group><year>2020</year><article-title>Health-Seeking Behavior of People in Indonesia:A Narrative Review</article-title><source>Journal of Epidemiology and Global Health</source><volume>10</volume><issue>1</issue><fpage>6</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">32175705</pub-id>
</element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>Y.J</given-names></name>
<name><surname>Noordin</surname><given-names>N.M</given-names></name>
<name><surname>Keshavjee</surname><given-names>S</given-names></name>
<name><surname>Lee</surname><given-names>S.W.H</given-names></name>
</person-group><year>2021</year><article-title>Impact of latent tuberculosis infection on health and wellbeing:a systematic review and meta-analysis</article-title><source>European Respiratory Review :an Official Journal of the European Respiratory Society</source><volume>30</volume><issue>159</issue><fpage>200260</fpage><pub-id pub-id-type="pmid">33408089</pub-id>
</element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yadav</surname><given-names>S</given-names></name>
</person-group><year>2024</year><article-title>Stigma in Tuberculosis:Time to Act on an Important and Largely Unaddressed Issue</article-title><source>Cureus</source><volume>16</volume><issue>6</issue><fpage>e61964</fpage><pub-id pub-id-type="pmid">38978939</pub-id>
</element-citation></ref></ref-list></back></article>